✦ LIBER ✦

Somatostatin (SS) and Gabexate (GM) Are Ineffective in Preventing Post-ERCP Complications

✍ Scribed by Angelo Andriulli; Luigi Solmi; Silvano Loperfido; Virginia Festa; Angelo Belmonte; Pietro Leo; Fulvio Spirito; Michele Silla; Giovanni Forte; Vittorio Terruzzi; Paolo Mescia; Enrico Ciliberto; Mauro Maglia; Fabio Monica; Francesco Perri

Book ID: 118524081
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 63 KB
Volume: 59
Category: Article
ISSN: 1097-6779
DOI: 10.1016/s0016-5107(04)00527-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatostatin (SS), gabexate (GM), or pla

Somatostatin (SS), gabexate (GM), or placebo (P) for the prevention of pancreatic damage related to ERCP in patients (pts) at high risk for pancreatitis

✍ Andriull, A; Clemente, R; Solmi, L; Perri, F; De Maio, G 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB